X4 Pharmaceuticals

XFOR

Börsenwert 321 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Ikarian Capital Dallas, Texas	17,7 Mio. $	+874.184 $	+3.477	+4 %
2	2 Bain Capital Life Sciences Investors Boston, Massachusetts	13,8 Mio. $	–	–	–
3	ACM 3 AIGH Capital Management Baltimore, Maryland	9,35 Mio. $	+12,1 Mio. $	+47.963	Neu
4	4 OrbiMed New York	8,93 Mio. $	–	–	–
5	5 Vanguard Group Malvern, Pennsylvania	5,83 Mio. $	+1,35 Mio. $	+5.368	+22 %
6	6 BVF Inc San Francisco, California	5,51 Mio. $	-2,04 Mio. $	-8.123	-22 %
7	7 Sio Capital Management New York	5,23 Mio. $	–	–	–
8	8 Driehaus Capital Management Chicago, Illinois	5,17 Mio. $	–	–	–
9	9 Monashee Investment Management Boston, Massachusetts	3,74 Mio. $	–	–	–
10	10 Axa Paris, France	3,7 Mio. $	-3.771 $	-15	-0,1 %
11	11 Millennium Management New York	2,51 Mio. $	+3,24 Mio. $	+12.867	Neu
12	12 New Leaf Venture Partners New York	2,18 Mio. $	–	–	–
13	13 Worth Venture Partners Fort Lee, New Jersey	2,18 Mio. $	+2,8 Mio. $	+11.156	Neu
14	14 Boothbay Fund Management New York	2,13 Mio. $	+164.679 $	+655	+6 %
15	15 Polaris Venture Management Co V Boston, Massachusetts	2,02 Mio. $	–	–	–
16	16 SV Health Investors Boston, Massachusetts	2,02 Mio. $	–	–	–
17	17 BlackRock New York	1,71 Mio. $	-6,94 Mio. $	-27.616	-76 %
18	18 Abingworth London, United Kingdom	1,49 Mio. $	–	–	–
19	19 Fidelity Investments Boston, Massachusetts	1,38 Mio. $	–	–	–
20	20 Hudson Bay Capital Management Stamford, Connecticut	1,08 Mio. $	–	–	–
21	21 Geode Capital Management Boston, Massachusetts	1,05 Mio. $	-806.804 $	-3.209	-37 %
22	22 Renaissance Technologies New York	850.000 $	-212.449 $	-845	-16 %
23	23 Dimensional Fund Advisors Austin, Texas	814.000 $	+653.689 $	+2.600	+165 %
24	24 Cormorant Asset Management Boston, Massachusetts	676.000 $	–	–	–
25	25 Prosight Management Dallas, Texas	571.000 $	+735.903 $	+2.927	Neu

X4 Pharmaceuticals XFOR Börsenwert 321 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 321 Mio. $